Aerovate Therapeutics
AVTE
#9229
Rank
โ‚น6.32 B
Marketcap
โ‚น218.14
Share price
0.40%
Change (1 day)
-90.11%
Change (1 year)

Revenue for Aerovate Therapeutics (AVTE)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aerovate Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A